A Double-blind Randomized Placebo-controlled Parallel Design Multicenter Phase IIIb Study of the Effect of Sodium Zirconium Cyclosilicate (SZC) on Serum Potassium and Serum Bicarbonate in Pateitns with Hyperkalemia and Metabolic Acidosis Associated with Chronic Kidney Disease (NEUTRALIZE)
This Study is
No Longer Enrolling
Description
This is a 36 day trial with 8 in-person visits comparing the effect of Lokelma vs. placebo on serum potassium and bicarbonate levels.
MoreDetails
Age
Adult
Eligibility
-18 years or older -CKD stage 3-5 with GFR of 30-59 -Potassium level of 5.1-5.9 -Carbon dioxide level of 16-20
Type of Study
Treatment
Locations
Renal Research Center
Study ID
Protocol Number: 21-2470
More information available at ClinicalTrials.gov: NCT04727528
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers